FTC asks court to hold Shkreli in contempt over alleged pharma ban violation

On Oct. 12, 2026, the Federal Trade Commission said it and states asked a federal court to hold Martin Shkreli in contempt for allegedly violating a lifetime ban from the pharmaceutical industry. The filing seeks a judicial finding. It is not itself a finding of violation.